Pharvaris PHVS
NASDAQ PHVS
$36.14 +0.48 (+1.35%)
As of: Sep 4, 2026 · 1:34 PM EDT

Pharvaris (PHVS) Tax Provisions (2021 - 2026)

Pharvaris' (PHVS) quarterly Tax Provisions came in at -$319738.8 in Q1 2026, little changed YoY from -$321118.8 in Q1 2025, and up 83.49% on a QoQ basis from -$1.9 million in Q4 2025.

Analysis

Pharvaris (PHVS) Tax Provisions (2021 - 2026) Analysis & Trends

Pharvaris (PHVS) has 6 years of Tax Provisions data on file, last reported at -$319738.8 in Q1 2026.

  • Quarterly Tax Provisions changed 0.43% year-over-year to -$319738.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (down 15.36% YoY) and the FY2025 annual result came in at -$2.2 million, down 13.7% from the prior year.
  • Tax Provisions improved to -$319738.8 in Q1 2026, from -$1.9 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.4 million in Q3 2022 to a low of -$2.9 million in Q2 2022.
  • A 5-year average of -$170454.8 and a median of -$159231.4 in 2023 frame the typical range for Tax Provisions.
  • The widest YoY moves for Tax Provisions: up 3114.12% in 2022, down 81815.03% in 2022.
  • Tracing PHVS's Tax Provisions over 5 years: stood at $1.1 million in 2022, then jumped by 34.94% to $1.5 million in 2023, then tumbled by 191.17% to -$1.3 million in 2024, then slumped by 46.27% to -$1.9 million in 2025, then jumped by 83.49% to -$319738.8 in 2026.
  • The last three Tax Provisions figures came in at -$319738.8 (Q1 2026), -$1.9 million (Q4 2025), and $212147.3 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn -59.00 Mn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 1.90 Mn
10 Pharvaris 2.13 Bn 1.76 Bn 85,072.10 -699,974.31
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -699,974.31
Mar 31, 2026 -319,738.83
Dec 31, 2025 -1.94 Mn
Sep 30, 2025 212,147.26
Jun 30, 2025 -229,541.05
Mar 31, 2025 -318,370.71
Dec 31, 2024 -1.32 Mn
Sep 30, 2024 -252,690.42
Jun 30, 2024 -76,053.03
Mar 31, 2024 -309,740.21
Dec 31, 2023 -804,477.04
Sep 30, 2023 -159,231.39
Jun 30, 2023 -102.55 Bn
Mar 31, 2023 -65,105.69
Dec 31, 2022 -309,337.98
Sep 30, 2022 2.42 Mn
Jun 30, 2022 -2,924.91 Bn
Mar 31, 2022 -43,451.30
Dec 31, 2021 22,452.72
Sep 30, 2021 -80,415.60